Hetrombopag Olamine Clinical Trials
3 recruitingDrug
Phase 22Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
Patients With Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd.150 enrolled7 locationsNCT07286032
Recruiting
Phase 2
TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination
Immune Thrombocytopenia
Peking Union Medical College Hospital56 enrolled1 locationNCT06478537
Recruiting
Phase 2
Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy
Radiotherapy Side EffectThrombocytopenia
Sir Run Run Shaw Hospital50 enrolled1 locationNCT06433830